Aspartocin D is a minor analog of the amphomycin complex, a family of lipopeptide antibiotics produced by Streptomyces canus, isolated and reported by researchers at Fujian Institute of Microbiology in China in 2014. Aspartocin D is active against Gram-positive bacteria and is presumed to act by inhibiting bacterial cell wall peptidoglycan synthesis, however its bioprofile and potential utility has not been extensively investigated.
Aspartocin D is soluble in ethanol, methanol, DMF and DMSO.
| Mechanism of Action | Aspartocin D is presumed to act by inhibiting bacterial cell wall peptidoglycan synthesis, however its bioprofile and potential utility has not been extensively investigated. |
| Molecular Formula | C56H87N13O20 |
| References | Heineman B et al (1953) Amphomycin. A new antibiotic. Antibiot. Chemother. 3:1239 Yan H et al (2014) Two novel amphomycin analogs from Streptomyces canus strain FIM-0916. Nat. Prod. Res. 28:861 |
